Patrick Nadeau, vice-president (business development, marketing and operations) of Lupin Pharma Canada, highlights the journey of Lupin Pharma within Canada since its 2014 establishment, the strategic importance of the Canadian affiliate within its mission to become a global pharma company in both the branded and the generics spaces, as well as his priorities for the affiliate for the next few years.
Patrick, to begin with, Lupin came to Canada in 2014. What was the rationale behind the establishment of the Canadian affiliate then?
"The key to success is to bring value – that is Lupin’s strategy in Canada and it has worked very well."
